Researchers showed that chemotherapy-resistant cancer cells use fructose to reprogram neighboring cells and facilitate dissemination in mice.
Category: biotech/medical – Page 93
Youth-associated protein helps restore healthy function in immune cells in the aging brain
Researchers at the Icahn School of Medicine at Mount Sinai have identified a role for the youth-associated protein TIMP2 in supporting the healthy function of microglia, the brain’s resident immune cells.
In a study published Aug. 12 in Nature Communications, they found that loss of TIMP2 caused microglia to develop several features associated with aging and neurodegeneration. Conversely, restoring TIMP2 in the blood of aged mice improved the ability of microglia to clear debris and reduced molecular markers associated with inflammation and other maladaptive states.
The findings provide new insight into how youth-associated factors may influence the aging brain and suggest that TIMP2 may help maintain healthy immune function in the brain as organisms age.
Ketamine and psychotherapy show promise as a combined approach to chronic neuropathic pain
Combining ketamine and psychotherapy is a safe and feasible approach with promising benefits for people experiencing chronic neuropathic pain, according to a new study by researchers at St. Michael’s Hospital, the University of Toronto and York University.
“This is a novel treatment paradigm for a patient population that is suffering greatly,” says Akash Goel, the study’s lead author, a clinician-investigator at St. Michael’s Hospital, a site of Unity Health Toronto, and an assistant professor of anesthesiology and pain medicine at the University of Toronto’s Temerty Faculty of Medicine.
The trial was conducted at St. Michael’s Hospital between 2023 and 2025 and enrolled 30 participants with chronic neuropathic pain who were randomly assigned to receive one of three treatments: ketamine infusions, weekly psychotherapy sessions or both. Each treatment program lasted 16 weeks.
Cells use a little-known molecule to protect themselves from iron overload
Iron is essential. Our cells need it to produce energy, carry oxygen throughout the body and power countless chemical reactions that sustain life. But this metal has a dark side. When too much of it is left free inside cells, it can trigger destructive reactions that break down DNA, proteins and even cell membranes.
Now, Whitehead Institute Member Ankur Jain, former postdoc Whitney Henry and graduate student Pushkal Sharma have discovered that cells rely on an unexpected protector against this threat: small molecules called polyamines.
The researchers’ detailed findings, published in the journal Cell, reveal that polyamines act like storage lockers for iron, safely holding the metal in a nonreactive state until cells need it.
Fructose Is an “Unexpected” Driver of Cancer Spread
Cancer cells that enter senescence after chemotherapy can still influence tumor progression. Researchers found that their secretome contains fructose, which alters cholesterol metabolism in neighboring cells and promotes metastasis.
Abstract: 1 Division of Endocrinology, Diabetes and Metabolism and the Joan and Sanford I
1 Division of Endocrinology, Diabetes and Metabolism and the Joan and Sanford I. Weill Center for Metabolic Health, Weill Cornell Medicine, New York, New York, USA.
2Diabetes Division, UMASS chan medical school, worcester, massachusetts, USA.
3Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Focal Therapy for Prostate Cancer
This retrospective study used the National Cancer Database (NCDB) to identify patients 50 years or older with nonmetastatic prostate cancer diagnosed between 2010 and 2023 and seen at US centers with Commission on Cancer accreditation.9 Treatment categories were derived from NCDB first-course treatment variables. The study was approved by the University of Pittsburgh institutional review board (STUDY26020146) and followed Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines.10
Inappropriate focal therapy use was defined as focal therapy in low-, high-, or very–high-risk disease.2 Intermediate-risk focal therapy was reported separately because the NCDB does not capture trial enrollment, registry participation, or lesion characteristics needed to classify appropriateness.
Temporal trends were assessed using Cochran-Armitage tests. Multivariable logistic regression evaluated patient-and facility-level characteristics associated with focal therapy vs radical prostatectomy. Adjusted predicted probabilities and average marginal effects were estimated using facility-clustered robust standard errors. The eMethods in Supplement 1 provide additional methodologic detail.
Intensification and Deintensification of Diabetes Medications Among Older Adults
This cohort study explores the prevalence of diabetes medication adjustment based on health status and hemoglobin A1c level among patients 65 years or older.
Navigating Challenges and Opportunities in MultiOmics Integration for Personalized Healthcare
The field of multi-omics has witnessed unprecedented growth, converging multiple scientific disciplines and technological advances. This surge is evidenced by a more than doubling in multi-omics scientific publications within just two years (2022–2023) since its first referenced mention in 2002, as indexed by the National Library of Medicine. This emerging field has demonstrated its capability to provide comprehensive insights into complex biological systems, representing a transformative force in health diagnostics and therapeutic strategies. However, several challenges are evident when merging varied omics data sets and methodologies, interpreting vast data dimensions, streamlining longitudinal sampling and analysis, and addressing the ethical implications of managing sensitive health information. This review evaluates these challenges while spotlighting pivotal milestones: the development of targeted sampling methods, the use of artificial intelligence in formulating health indices, the integration of sophisticated n-of-1 statistical models such as digital twins, and the incorporation of blockchain technology for heightened data security. For multi-omics to truly revolutionize healthcare, it demands rigorous validation, tangible real-world applications, and smooth integration into existing healthcare infrastructures. It is imperative to address ethical dilemmas, paving the way for the realization of a future steered by omics-informed personalized medicine.
Bacteria share proteins to survive antibiotics
Researchers found that some bacteria share proteins that help others survive antibiotics.









